S&P 500   3,929.60 (-1.73%)
DOW   33,512.87 (-1.28%)
QQQ   280.40 (-2.52%)
AAPL   142.07 (-3.11%)
MSFT   244.17 (-2.41%)
META   113.82 (-7.03%)
GOOGL   96.51 (-2.99%)
AMZN   88.18 (-3.11%)
TSLA   178.92 (-1.93%)
NVDA   158.37 (-4.65%)
NIO   13.15 (+2.73%)
BABA   90.98 (+0.51%)
AMD   69.48 (-5.62%)
T   19.08 (+1.76%)
MU   53.34 (-1.30%)
CGC   3.59 (-16.90%)
F   13.20 (-1.35%)
GE   84.63 (-0.04%)
DIS   92.14 (-3.95%)
AMC   6.75 (-9.40%)
PYPL   71.78 (-2.50%)
PFE   49.41 (-2.60%)
NFLX   304.44 (-2.61%)
S&P 500   3,929.60 (-1.73%)
DOW   33,512.87 (-1.28%)
QQQ   280.40 (-2.52%)
AAPL   142.07 (-3.11%)
MSFT   244.17 (-2.41%)
META   113.82 (-7.03%)
GOOGL   96.51 (-2.99%)
AMZN   88.18 (-3.11%)
TSLA   178.92 (-1.93%)
NVDA   158.37 (-4.65%)
NIO   13.15 (+2.73%)
BABA   90.98 (+0.51%)
AMD   69.48 (-5.62%)
T   19.08 (+1.76%)
MU   53.34 (-1.30%)
CGC   3.59 (-16.90%)
F   13.20 (-1.35%)
GE   84.63 (-0.04%)
DIS   92.14 (-3.95%)
AMC   6.75 (-9.40%)
PYPL   71.78 (-2.50%)
PFE   49.41 (-2.60%)
NFLX   304.44 (-2.61%)
S&P 500   3,929.60 (-1.73%)
DOW   33,512.87 (-1.28%)
QQQ   280.40 (-2.52%)
AAPL   142.07 (-3.11%)
MSFT   244.17 (-2.41%)
META   113.82 (-7.03%)
GOOGL   96.51 (-2.99%)
AMZN   88.18 (-3.11%)
TSLA   178.92 (-1.93%)
NVDA   158.37 (-4.65%)
NIO   13.15 (+2.73%)
BABA   90.98 (+0.51%)
AMD   69.48 (-5.62%)
T   19.08 (+1.76%)
MU   53.34 (-1.30%)
CGC   3.59 (-16.90%)
F   13.20 (-1.35%)
GE   84.63 (-0.04%)
DIS   92.14 (-3.95%)
AMC   6.75 (-9.40%)
PYPL   71.78 (-2.50%)
PFE   49.41 (-2.60%)
NFLX   304.44 (-2.61%)
S&P 500   3,929.60 (-1.73%)
DOW   33,512.87 (-1.28%)
QQQ   280.40 (-2.52%)
AAPL   142.07 (-3.11%)
MSFT   244.17 (-2.41%)
META   113.82 (-7.03%)
GOOGL   96.51 (-2.99%)
AMZN   88.18 (-3.11%)
TSLA   178.92 (-1.93%)
NVDA   158.37 (-4.65%)
NIO   13.15 (+2.73%)
BABA   90.98 (+0.51%)
AMD   69.48 (-5.62%)
T   19.08 (+1.76%)
MU   53.34 (-1.30%)
CGC   3.59 (-16.90%)
F   13.20 (-1.35%)
GE   84.63 (-0.04%)
DIS   92.14 (-3.95%)
AMC   6.75 (-9.40%)
PYPL   71.78 (-2.50%)
PFE   49.41 (-2.60%)
NFLX   304.44 (-2.61%)
NYSE:PFE

Pfizer - PFE Stock Forecast, Price & News

$49.41
-1.32 (-2.60%)
(As of 12/6/2022 03:28 PM ET)
Add
Compare
Today's Range
$49.18
▼
$50.84
50-Day Range
$41.75
▼
$51.08
52-Week Range
$41.44
▼
$61.71
Volume
730,044 shs
Average Volume
17.93 million shs
Market Capitalization
$277.35 billion
P/E Ratio
9.50
Dividend Yield
3.14%
Price Target
$56.47

Pfizer MarketRank™ Forecast

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
14.0% Upside
$56.47 Price Target
Short Interest
Healthy
1.25% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.28mentions of Pfizer in the last 14 days
Based on 22 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-24.92%
From $6.46 to $4.85 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.91 out of 5 stars

Medical Sector

34th out of 1,023 stocks

Pharmaceutical Preparations Industry

13th out of 501 stocks

See Top Rated MarketRank™ Stocks Here
PFE stock logo

About Pfizer (NYSE:PFE) Stock

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Receive PFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat's FREE daily newsletter.

PFE Stock News Headlines

December 5, 2022 | marketbeat.com
Pfizer asks FDA to clear updated COVID shot for kids under 5
Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5
December 2, 2022 | marketbeat.com
Asian shares sink on revived worries over recession, China
Shares have retreated in Asia after a mixed day on Wall Street
November 30, 2022 | marketbeat.com
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk (PFE)
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment
November 30, 2022 | marketbeat.com
Chinese vaccine plans spark hope for end of 'zero COVID'
A campaign to vaccinate older Chinese has sparked hopes Beijing might roll back severe anti-virus controls that prompted angry protesters to demand President Xi Jinping resign
November 18, 2022 | marketbeat.com
Pfizer booster spurs immune response to new omicron subtypes
Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though it’s not an exact match
November 16, 2022 | marketbeat.com
Four Healthcare Stocks To Watch This Week (PFE)
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.
November 16, 2022 | marketbeat.com
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market? (PFE)
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
November 7, 2022 | marketbeat.com
BioNTech earnings drop but forecast for vaccine income grows
BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier
December 6, 2022 | cnbc.com
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history
December 6, 2022 | finance.yahoo.com
Pfizer's (NYSE:PFE) investors will be pleased with their notable 77% return over the last five years
December 5, 2022 | investing.com
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
December 5, 2022 | finance.yahoo.com
Covid-19 Cases Are Rising Again. A Winter Wave Could Be Coming.
December 5, 2022 | finance.yahoo.com
Pfizer, BioNTech ask FDA to authorize bivalent COVID vaccine in young children
December 5, 2022 | finance.yahoo.com
China begins to loosen COVID rules
December 5, 2022 | finance.yahoo.com
Will Pfizer Shares Break Out or Reverse to the Downside?
December 5, 2022 | finance.yahoo.com
UPDATE 1-Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5
December 2, 2022 | fool.com
Why Shares of Prometheus Biosciences Slumped This Week
December 2, 2022 | finance.yahoo.com
Pfizer to invest more than $2.5 bln to expand European manufacturing
December 2, 2022 | ca.finance.yahoo.com
Pfizer to invest more than $2.5 billion to expand European manufacturing
December 2, 2022 | finance.yahoo.com
Shareholders may not want to ignore the US$8.2m worth sales made by Pfizer Inc. (NYSE:PFE) insiders this past year
December 1, 2022 | fool.com
Why Roivant Sciences' Shares Are Up Thursday
November 30, 2022 | finance.yahoo.com
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
November 30, 2022 | finance.yahoo.com
Why Pfizer Stock Is a Surefire Winner in 2023
November 29, 2022 | seekingalpha.com
Pfizer: COVID-19 May Never End
November 28, 2022 | benzinga.com
UK Study Finds Pfizer/Bristol Myers Clotting Drug Does Not Help COVID-19 Patients
See More Headlines
Receive PFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat's FREE daily newsletter.

PFE Company Calendar

Last Earnings
11/02/2021
Ex-Dividend for 12/5 Dividend
11/03/2022
Dividend Payable
12/05/2022
Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/14/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSE:PFE
CUSIP
71708110
CIK
78003
Web
www.pfizer.com
Phone
(212) 733-2323
Fax
302-655-5049
Employees
79,000
Year Founded
1849

Price Target and Rating

Average Stock Price Forecast
$56.47
High Stock Price Forecast
$76.00
Low Stock Price Forecast
$44.00
Forecasted Upside/Downside
+14.3%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
14 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$5.20
Trailing P/E Ratio
9.50
Forward P/E Ratio
7.65
P/E Growth
0.88
Net Income
$21.98 billion
Net Margins
29.81%
Pretax Margin
33.37%
Return on Equity
43.95%
Return on Assets
19.80%

Debt

Debt-to-Equity Ratio
0.35
Current Ratio
1.59
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$81.29 billion
Price / Sales
3.41
Cash Flow
$5.26 per share
Price / Cash Flow
9.39
Book Value
$13.80 per share
Price / Book
3.58

Miscellaneous

Outstanding Shares
5,613,310,000
Free Float
5,610,507,000
Market Cap
$277.35 billion
Optionable
Optionable
Beta
0.70

Social Links


Key Executives

  • Dr. Albert Bourla D.V.M.Dr. Albert Bourla D.V.M. (Age 60)
    DVM, Ph.D., Chairman & CEO
    Comp: $11.07M
  • Mr. Frank A. D'Amelio (Age 64)
    CFO & Exec. VP
    Comp: $5.14M
  • Dr. Mikael Dolsten M.D. (Age 64)
    Ph.D., Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical
    Comp: $5.36M
  • Mr. Douglas M. LanklerMr. Douglas M. Lankler (Age 56)
    Exec. VP & Gen. Counsel
    Comp: $3.78M
  • Mr. John D. YoungMr. John D. Young (Age 57)
    Advisor
    Comp: $4.25M
  • Ms. Angela Hwang (Age 56)
    Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus.
    Comp: $4.79M
  • Mr. David M. Denton (Age 57)
    Chief Financial Officer & Exec. VP
  • Ms. Jennifer B. DamicoMs. Jennifer B. Damico (Age 54)
    Sr. VP, Controller & Principal Accounting Officer
  • Ms. Lidia L. Fonseca (Age 53)
    Exec. VP and Chief Digital & Technology Officer
  • Mr. Christopher J. Stevo CFA
    Sr. VP & Chief Investor Relations Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PFE Stock - Frequently Asked Questions

Should I buy or sell Pfizer stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" PFE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PFE, but not buy additional shares or sell existing shares.
View PFE analyst ratings or view top-rated stocks.

What is Pfizer's stock price forecast for 2023?

14 analysts have issued 12-month price targets for Pfizer's shares. Their PFE share price forecasts range from $44.00 to $76.00. On average, they expect the company's share price to reach $56.47 in the next year. This suggests a possible upside of 13.2% from the stock's current price.
View analysts price targets for PFE or view top-rated stocks among Wall Street analysts.

How have PFE shares performed in 2022?

Pfizer's stock was trading at $59.05 at the start of the year. Since then, PFE shares have decreased by 15.5% and is now trading at $49.89.
View the best growth stocks for 2022 here.

Are investors shorting Pfizer?

Pfizer saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 70,040,000 shares, an increase of 28.1% from the October 31st total of 54,690,000 shares. Based on an average trading volume of 19,640,000 shares, the days-to-cover ratio is currently 3.6 days.
View Pfizer's Short Interest.

When is Pfizer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our PFE earnings forecast.

How were Pfizer's earnings last quarter?

Pfizer Inc. (NYSE:PFE) issued its quarterly earnings results on Tuesday, November, 2nd. The biopharmaceutical company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.08 by $0.26. The biopharmaceutical company had revenue of $24.09 billion for the quarter, compared to analysts' expectations of $22.82 billion. Pfizer had a trailing twelve-month return on equity of 43.95% and a net margin of 29.81%. The company's revenue for the quarter was up 134.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.72 earnings per share.
Read the conference call transcript.

How often does Pfizer pay dividends? What is the dividend yield for Pfizer?

Pfizer announced a quarterly dividend on Thursday, September 22nd. Investors of record on Friday, November 4th will be given a dividend of $0.40 per share on Monday, December 5th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.21%. The ex-dividend date is Thursday, November 3rd.
Read our dividend analysis for PFE.

Is Pfizer a good dividend stock?

Pfizer (NYSE:PFE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.14%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 30.77%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PFE will have a dividend payout ratio of 32.99% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PFE.

What guidance has Pfizer issued on next quarter's earnings?

Pfizer updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share guidance of $6.40-$6.50 for the period, compared to the consensus estimate of $6.38. The company issued revenue guidance of $99.50 billion-$102.00 billion, compared to the consensus revenue estimate of $99.60 billion.

What is Albert Bourla's approval rating as Pfizer's CEO?

358 employees have rated Pfizer Chief Executive Officer Albert Bourla on Glassdoor.com. Albert Bourla has an approval rating of 92% among the company's employees. This puts Albert Bourla in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pfizer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Exxon Mobil (XOM), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

What is Pfizer's stock symbol?

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Who are Pfizer's major shareholders?

Pfizer's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.79%), BlackRock Inc. (7.71%), State Street Corp (5.12%), Bank of New York Mellon Corp (1.01%), Massachusetts Financial Services Co. MA (0.74%) and Dimensional Fund Advisors LP (0.73%). Insiders that own company stock include Alexander R Mackenzie, Douglas M Lankler, Jennifer B Damico, John D Young, Pfizer Inc, Ronald E Blaylock, Scott Gottlieb and William R Carapezzi Jr.
View institutional ownership trends.

How do I buy shares of Pfizer?

Shares of PFE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pfizer's stock price today?

One share of PFE stock can currently be purchased for approximately $49.89.

How much money does Pfizer make?

Pfizer (NYSE:PFE) has a market capitalization of $280.05 billion and generates $81.29 billion in revenue each year. The biopharmaceutical company earns $21.98 billion in net income (profit) each year or $5.20 on an earnings per share basis.

How many employees does Pfizer have?

The company employs 79,000 workers across the globe.

Does Pfizer have any subsidiaries?
The following companies are subsidiares of Pfizer: AH Robins LLC, AHP Holdings B.V., AHP Manufacturing B.V., Agouron Pharmaceuticals LLC, Alacer, Alpharma Holdings LLC, Alpharma Pharmaceuticals LLC, Alpharma Specialty Pharma LLC, Alpharma USHP LLC, American Food Industries LLC, Anacor Pharmaceuticals, Anacor Pharmaceuticals Inc., Angiosyn, Array BioPharma, Ayerst-Wyeth Pharmaceuticals LLC, BIND Therapeutics Inc., BINESA 2002 S.L., Bamboo Therapeutics, Bamboo Therapeutics Inc., Baxter International - Marketed Vaccines, BioRexis, Bioren, Bioren LLC, Blue Whale Re Ltd., C.E. Commercial Holdings C.V., C.E. Commercial Investments C.V., C.P. Pharmaceuticals International C.V., CICL Corporation, COC I Corporation, Catapult Genetics, Coley Pharmaceutical GmbH, Coley Pharmaceutical Group, Coley Pharmaceutical Group Inc., Continental Pharma Inc., Covx, Covx Technologies Ireland Limited, Cyanamid Inter-American Corporation, Cyanamid de Argentina S.A., Cyanamid de Colombia S.A., Distribuidora Mercantil Centro Americana S.A., Encysive Pharmaceuticals, Encysive Pharmaceuticals Inc., Esperion LUV Development Inc., Esperion Therapeutics, Excaliard Pharmaceuticals, Excaliard Pharmaceuticals Inc., Farminova Produtos Farmaceuticos de Inovacao Lda., Farmogene Productos Farmaceuticos Lda, Ferrosan A/S, Ferrosan International A/S, Ferrosan S.R.L., FoldRx Pharmaceuticals Inc., Foldrx Pharmaceuticals, Fort Dodge Manufatura Ltda., G. D. Searle & Co. Limited, G. D. Searle International Capital LLC, G. D. Searle LLC, GI Europe Inc., GI Japan Inc., GenTrac Inc., Genetics Institute LLC, Greenstone LLC, Haptogen Limited, Hospira, Hospira (China) Enterprise Management Co. Ltd., Hospira Adelaide Pty Ltd, Hospira Aseptic Services Limited, Hospira Australia Pty Ltd, Hospira Benelux BVBA, Hospira Chile Limitada, Hospira Deutschland GmbH, Hospira Enterprises B.V., Hospira France SAS, Hospira Healthcare B.V., Hospira Healthcare Corporation, Hospira Healthcare India Private Limited, Hospira Holdings (S.A.) Pty Ltd, Hospira Inc., Hospira Invicta S.A., Hospira Ireland Holdings Unlimited Company, Hospira Ireland Sales Limited, Hospira Japan G.K., Hospira Limited, Hospira Malaysia Sdn Bhd, Hospira NZ Limited, Hospira Nordic AB, Hospira Philippines Inc., Hospira Portugal LDA, Hospira Produtos Hospitalares Ltda., Hospira Pte. Ltd., Hospira Pty Limited, Hospira Puerto Rico LLC, Hospira Singapore Pte Ltd, Hospira UK Limited, Hospira Worldwide LLC, Hospira Zagreb d.o.o., ICAgen, Idun Pharmaceuticals, Industrial Santa Agape S.A., InnoPharma, InnoPharma Inc., International Affiliated Corporation LLC, JMI-Daniels Pharmaceuticals Inc., John Wyeth & Brother Limited, Kiinteistö oy Espoon Pellavaniementie 14, King Pharmaceuticals Holdings LLC, King Pharmaceuticals LLC, King Pharmaceuticals Research and Development LLC, Korea Pharma Holding Company Limited, Laboratoires Pfizer S.A., Laboratorios Parke Davis S.L., Laboratorios Pfizer Ltda., Laboratorios Wyeth LLC, Laboratorios Wyeth S.A., Laboratórios Pfizer Lda., MTG Divestitures LLC, Mayne Pharma IP Holdings (Euro) Pty Ltd, Medivation, Medivation Field Solutions LLC, Medivation LLC, Medivation Neurology LLC, Medivation Prostate Therapeutics LLC, Medivation Services LLC, Medivation Technologies LLC, Meridian Medical Technologies Inc., Meridian Medical Technologies Limited, Monarch Pharmaceuticals LLC, Neusentis Limited, NextWave Pharmaceuticals, NextWave Pharmaceuticals Incorporated, P-D Co. LLC, PAH USA IN8 LLC, PF Americas Holding C.V., PF Asia Manufacturing B.V., PF PR Holdings C.V., PF PRISM C.V., PF PRISM Holdings S.a.r.l., PF Prism S.á.r.l., PFE Holdings G.K., PFE PHAC Holdings 1 LLC, PFE Pfizer Holdings 1 LLC, PFE Wyeth Holdings LLC, PFE Wyeth-Ayerst (Asia) LLC, PHILCO Holdings S.à r.l., PHIVCO Corp., PHIVCO Holdco S.à r.l., PHIVCO Luxembourg S.à r.l., PN Mexico LLC, PT. Pfizer Parke Davis, Parke Davis & Company LLC, Parke Davis Limited, Parke Davis Productos Farmaceuticos Lda, Parke-Davis Manufacturing Corp., Parkedale Pharmaceuticals Inc., Peak Enterprises LLC, Pfizer, Pfizer (China) Research and Development Co. Ltd., Pfizer (Malaysia) Sdn Bhd, Pfizer (Perth) Pty Limited, Pfizer (Thailand) Limited, Pfizer (Wuhan) Research and Development Co. Ltd., Pfizer AB, Pfizer AG, Pfizer AS, Pfizer Africa & Middle East for Pharmaceuticals Veterinarian Products & Chemicals S.A.E., Pfizer Anti-Infectives AB, Pfizer ApS, Pfizer Asia Manufacturing Pte. Ltd., Pfizer Asia Pacific Pte Ltd., Pfizer Atlantic Holdings S.a.r.l., Pfizer Australia Holdings B.V., Pfizer Australia Holdings Pty Limited, Pfizer Australia Investments Pty. Ltd., Pfizer Australia Pty Limited, Pfizer B.V., Pfizer BH D.o.o., Pfizer Baltic Holdings B.V., Pfizer Biofarmacêutica Sociedade Unipessoal Lda, Pfizer Biologics (Hangzhou) Co. Ltd, Pfizer Biologics Ireland Holdings Limited, Pfizer Biotech Corporation, Pfizer Bolivia S.A., Pfizer Canada Inc., Pfizer CentreSource Asia Pacific Pte. Ltd., Pfizer Chile S.A., Pfizer Cia. Ltda., Pfizer Colombia Spinco I LLC, Pfizer Commercial Holdings Coöperatief U.A., Pfizer Commercial Holdings TRAE Kft., Pfizer Commercial TRAE Trading Kft., Pfizer Consumer Healthcare AB, Pfizer Consumer Healthcare GmbH, Pfizer Consumer Healthcare Ltd., Pfizer Consumer Manufacturing Italy S.r.l., Pfizer Corporation, Pfizer Corporation Austria Gesellschaft m.b.H., Pfizer Corporation Hong Kong Limited, Pfizer Croatia d.o.o., Pfizer Deutschland GmbH, Pfizer Development LP, Pfizer Development Services (UK) Limited, Pfizer Domestic Ventures Limited, Pfizer Dominicana S.R.L, Pfizer ESP Pty Ltd, Pfizer East India B.V., Pfizer Eastern Investments B.V., Pfizer Egypt S.A.E., Pfizer Enterprise Holdings B.V., Pfizer Enterprises LLC, Pfizer Enterprises SARL, Pfizer Europe Finance B.V., Pfizer Export B.V., Pfizer Export Company, Pfizer Export Holding Company B.V, Pfizer Finance Share Service (Dalian) Co. Ltd., Pfizer Financial Services N.V./S.A., Pfizer France International Investments, Pfizer Free Zone Panama S. de R.L., Pfizer GEP S.L., Pfizer Global Holdings B.V., Pfizer Global Supply Japan Inc., Pfizer Global Trading, Pfizer Group Luxembourg Sarl, Pfizer Gulf FZ-LLC, Pfizer H.C.P. Corporation, Pfizer HK Service Company Limited, Pfizer Health AB, Pfizer Health Solutions Inc., Pfizer Healthcare Ireland, Pfizer Hellas A.E., Pfizer Himalaya Holdings Coöperatief U.A., Pfizer Holding France, Pfizer Holding Ventures, Pfizer Holdings Corporation, Pfizer Holdings Europe Unlimited Company, Pfizer Holdings G.K., Pfizer Holdings International Corporation, Pfizer Holdings International Luxembourg (PHIL) Sarl, Pfizer Holdings North America SARL, Pfizer Hungary Holdings TRAE Kft., Pfizer Inc., Pfizer Innovations AB, Pfizer Innovations LLC, Pfizer Innovative Supply Point International BVBA, Pfizer International LLC, Pfizer International Markets Coöperatief U.A., Pfizer International Operations, Pfizer International S. de R.L., Pfizer International Trading (Shanghai) Limited, Pfizer Investment Capital Unlimited Company, Pfizer Investment Co. Ltd., Pfizer Investment Holdings S.a.r.l., Pfizer Ireland Investments Limited, Pfizer Ireland PFE Holding 1 LLC, Pfizer Ireland PFE Holding 2 LLC, Pfizer Ireland Pharmaceuticals, Pfizer Ireland Ventures Unlimited Company, Pfizer Italia S.r.l., Pfizer Italy Group Holding S.r.l., Pfizer Japan Inc., Pfizer LLC, Pfizer Laboratories (Pty) Limited, Pfizer Laboratories Limited, Pfizer Laboratories PFE (Pty) Ltd, Pfizer Leasing Ireland Limited, Pfizer Leasing UK Limited, Pfizer Limitada, Pfizer Limited, Pfizer Luxco Holdings SARL, Pfizer Luxembourg Global Holdings S.à r.l., Pfizer Luxembourg SARL, Pfizer MAP Holding Inc., Pfizer Manufacturing Austria G.m.b.H., Pfizer Manufacturing Belgium N.V., Pfizer Manufacturing Deutschland GmbH, Pfizer Manufacturing Deutschland Grundbesitz GmbH & Co. KG, Pfizer Manufacturing Holdings LLC, Pfizer Manufacturing Ireland Unlimited Company, Pfizer Manufacturing LLC, Pfizer Manufacturing Services, Pfizer Medical Technology Group (Belgium) N.V., Pfizer Medicamentos Genericos e Participacoes Ltda., Pfizer Mexico Luxco SARL, Pfizer Mexico S.A. de C.V., Pfizer Middle East for Pharmaceuticals Animal Health and Chemicals S.A.E., Pfizer New Zealand Limited, Pfizer Norge AS, Pfizer North American Holdings Inc., Pfizer OTC B.V., Pfizer Overseas LLC, Pfizer Oy, Pfizer PFE ApS, Pfizer PFE AsiaPac Holding B.V., Pfizer PFE Australia Holding B.V., Pfizer PFE Australia Pty Ltd, Pfizer PFE B.V., Pfizer PFE Baltic Holdings B.V., Pfizer PFE Belgium SPRL, Pfizer PFE Brazil Holding S.à r.l., Pfizer PFE CIA. Ltda., Pfizer PFE Chile Holding LLC, Pfizer PFE Colombia Holding Corp., Pfizer PFE Colombia S.A.S, Pfizer PFE Commercial Holdings LLC, Pfizer PFE Croatia Holding B.V., Pfizer PFE Eastern Investments B.V., Pfizer PFE Finland Oy, Pfizer PFE France, Pfizer PFE Global Holdings B.V., Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer PFE Italy Holdco 2 S.à r.l., Pfizer PFE Italy Holdco S.à r.l., Pfizer PFE Korlátolt Felelősségű Társaság, Pfizer PFE Limited, Pfizer PFE Luxembourg S.à r.l., Pfizer PFE Mexico Holding 3 LLC, Pfizer PFE Netherlands Holding 1 C.V., Pfizer PFE New Zealand, Pfizer PFE New Zealand Holding B.V., Pfizer PFE Norway Holding S.à r.l., Pfizer PFE PILSA Holdco S.à r.l., Pfizer PFE Peru Holding LLC, Pfizer PFE Peru S.R.L., Pfizer PFE Pharmaceuticals Israel Holding LLC, Pfizer PFE Pharmaceuticals Israel Ltd., Pfizer PFE Private Limited, Pfizer PFE S.R.L, Pfizer PFE Service Company Holding Coöperatief U.A., Pfizer PFE Singapore Holding B.V., Pfizer PFE Singapore Pte. Ltd., Pfizer PFE Spain B.V., Pfizer PFE Spain Holding S.L., Pfizer PFE Sweden Holding 2 S.á.r.l., Pfizer PFE Sweden Holding S.á.r.l., Pfizer PFE Switzerland GmbH, Pfizer PFE Turkey Holding 1 B.V., Pfizer PFE Turkey Holding 2 B.V., Pfizer PFE UK Holding 4 LP, Pfizer PFE US Holdings 1 LLC, Pfizer PFE US Holdings 2 LLC, Pfizer PFE US Holdings 3 LLC, Pfizer PFE US Holdings 4 LLC, Pfizer PFE US Holdings 5 LLC, Pfizer PFE spol. s r.o., Pfizer PFE İlaçları Anonim Şirketi, Pfizer Pakistan Limited, Pfizer Parke Davis (Thailand) Ltd., Pfizer Parke Davis Inc., Pfizer Parke Davis Sdn. Bhd., Pfizer Pharm Algerie, Pfizer Pharma GmbH, Pfizer Pharma PFE GmbH, Pfizer Pharmaceutical (Wuxi) Co. Ltd., Pfizer Pharmaceutical Trading Limited Liability Company (a/k/a Pfizer Kft. or Pfizer LLC), Pfizer Pharmaceuticals B.V., Pfizer Pharmaceuticals Global B.V., Pfizer Pharmaceuticals Israel Ltd., Pfizer Pharmaceuticals Korea Limited, Pfizer Pharmaceuticals LLC, Pfizer Pharmaceuticals Ltd., Pfizer Pigments Inc., Pfizer Polska Sp. z.o.o., Pfizer Private Limited, Pfizer Production LLC, Pfizer Products Inc., Pfizer Products India Private Limited, Pfizer Research (NC) Inc., Pfizer Romania SRL, Pfizer S.A., Pfizer S.A., Pfizer S.A. (Belgium), Pfizer S.A. de C.V., Pfizer S.A.S., Pfizer S.G.P.S. Lda., Pfizer S.L., Pfizer S.R.L., Pfizer SRB d.o.o., Pfizer Saidal Manufacturing, Pfizer Santé Familiale, Pfizer Saudi Limited, Pfizer Seiyaku K.K., Pfizer Service Company BVBA, Pfizer Service Company Ireland Unlimited Company, Pfizer Services 1, Pfizer Services LLC, Pfizer Shared Services Unlimited Company, Pfizer Shareholdings Intermediate SARL, Pfizer Singapore Holding Pte. Ltd., Pfizer Singapore Trading Pte. Ltd., Pfizer Spain Holdings Coöperatief U.A., Pfizer Specialties Limited, Pfizer Strategic Investment Holdings LLC, Pfizer Sweden Partnership KB, Pfizer TRAE Holdings Kft., Pfizer Trading Polska sp.z.o.o., Pfizer Transactions Ireland Unlimited Company, Pfizer Transactions LLC, Pfizer Transactions Luxembourg SARL, Pfizer Transport LLC, Pfizer Ukraine LLC, Pfizer Vaccines LLC, Pfizer Venezuela S.A., Pfizer Venture Investments LLC, Pfizer Ventures LLC, Pfizer Worldwide Services Unlimited Company, Pfizer Zona Franca S.A., Pfizer spol. s r.o., Pharmacia, Pharmacia & Upjohn Company Inc., Pharmacia & Upjohn Company LLC, Pharmacia & Upjohn LLC, Pharmacia & Upjohn S.A. de C.V., Pharmacia Brasil Ltda., Pharmacia Hepar LLC, Pharmacia Holding AB, Pharmacia Inter-American LLC, Pharmacia International B.V., Pharmacia LLC, Pharmacia Limited, Pharmacia Nostrum S.A., Pharmacia South Africa (Pty) Ltd, PowderJect Research Limited, PowderMed, Purepac Pharmaceutical Holdings LLC, Redvax, Renrall LLC, Rinat Neuroscience, Rinat Neuroscience Corp., Roerig Produtos Farmaceuticos Lda., Roerig S.A., Sao Cristovao Participacoes Ltda., Searle Laboratorios Lda., Serenex, Servicios P&U S. de R.L. de C.V., Shiley LLC, Sinergis Farma-Produtos Farmaceuticos Lda., Site Realty Inc., Solinor LLC, Sugen LLC, Tabor LLC, The Pfizer Incubator LLC, Therachon, Thiakis Limited, Treerly Health Co. Ltd, US Oral Pharmaceuticals Pty Ltd, Upjohn Laboratorios Lda., Vesterålens Naturprodukter A/S, Vesterålens Naturprodukter AB, Vesterålens Naturprodukter AS, Vesterålens Naturprodukter OY, Vicuron Holdings LLC, Vinci Farma S.A., W-L LLC, Warner Lambert, Warner Lambert Ilac Sanayi ve Ticaret Limited Sirketi, Warner Lambert del Uruguay S.A., Warner-Lambert (Thailand) Limited, Warner-Lambert Company AG, Warner-Lambert Company LLC, Warner-Lambert Guatemala Sociedad Anonima, Warner-Lambert S.A., Whitehall International Inc., Whitehall Laboratories Inc., Wyeth (Thailand) Ltd., Wyeth AB, Wyeth Australia Pty. Limited, Wyeth Ayerst Inc., Wyeth Ayerst S.à r.l., Wyeth Biopharma, Wyeth Canada ULC, Wyeth Consumer Healthcare LLC, Wyeth Europa Limited, Wyeth Farma S.A., Wyeth Holdings LLC, Wyeth Industria Farmaceutica Ltda., Wyeth KFT., Wyeth LLC, Wyeth Lederle S.r.l., Wyeth Lederle Vaccines S.A., Wyeth Pakistan Limited, Wyeth Pharmaceutical Co. Ltd., Wyeth Pharmaceuticals Company, Wyeth Pharmaceuticals FZ-LLC, Wyeth Pharmaceuticals LLC, Wyeth Pharmaceuticals Limited, Wyeth Puerto Rico Inc., Wyeth S.A.S, Wyeth Subsidiary Illinois Corporation, Wyeth Whitehall Export GmbH, Wyeth Whitehall SARL, Wyeth-Ayerst (Asia) Limited, Wyeth-Ayerst International LLC, and Wyeth-Ayerst Promotions Limited.
Read More
How can I contact Pfizer?

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The official website for the company is www.pfizer.com. The biopharmaceutical company can be reached via phone at (212) 733-2323 or via fax at 302-655-5049.

This page (NYSE:PFE) was last updated on 12/6/2022 by MarketBeat.com Staff